|
(単位:千ドル)
|
2012/1
|
2013/1
|
2014/1
|
2015/1
|
2016/1
|
2017/1
|
2018/1
|
2019/1
|
2020/1
|
2021/1
|
2022/1
|
2023/1
|
2024/1
|
2025/1
|
|
売上高
|
79,193
|
61,224
|
68,592
|
88,347
|
94,658
|
98,448
|
113,401
|
136,657
|
133,446
|
116,033
|
117,480
|
142,527
|
148,086
|
151,283
|
|
売上成長率(%)
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
売上原価
|
47,410
|
37,496
|
41,609
|
51,370
|
56,500
|
58,959
|
69,399
|
82,658
|
84,688
|
74,673
|
73,741
|
94,371
|
96,465
|
98,534
|
|
売上総利益
|
31,783
|
23,728
|
26,983
|
36,977
|
38,158
|
39,489
|
44,002
|
53,999
|
48,758
|
41,360
|
43,739
|
48,156
|
51,621
|
52,749
|
|
売上総利益率(%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
研究開発費
|
5,243
|
3,816
|
5,072
|
5,802
|
6,945
|
6,314
|
7,453
|
7,813
|
8,084
|
6,206
|
6,753
|
6,822
|
6,906
|
6,610
|
|
営業費用
|
27,185
|
20,802
|
25,450
|
29,746
|
32,224
|
33,208
|
38,590
|
45,279
|
46,325
|
38,927
|
39,483
|
42,713
|
42,825
|
61,389
|
|
営業利益
|
3,916
|
2,926
|
1,533
|
7,231
|
5,934
|
6,281
|
5,412
|
8,720
|
2,433
|
2,433
|
4,256
|
5,443
|
8,796
|
-8,640
|
|
営業利益率 (%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
経常(税引前)利益
|
4,232
|
2,885
|
1,412
|
6,932
|
6,909
|
6,605
|
5,157
|
7,308
|
1,370
|
2,179
|
7,034
|
3,410
|
6,073
|
-12,287
|
|
経常(税引前)利益率(%)
|
5.34
|
4.71
|
2.06
|
7.85
|
7.3
|
6.71
|
4.55
|
5.35
|
1.03
|
1.88
|
5.99
|
2.39
|
4.1
|
-8.12
|
|
法人税等合計
|
1,100
|
847
|
175
|
2,270
|
2,384
|
2,377
|
1,871
|
1,578
|
-389
|
895
|
605
|
749
|
1,379
|
2,202
|
|
実効税率(%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
純利益
|
3,131
|
10,767
|
3,212
|
4,662
|
4,525
|
4,228
|
3,286
|
5,730
|
1,759
|
1,284
|
6,429
|
2,661
|
4,694
|
-14,489
|
|
純利益率(%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
一株あたり利益
|
0.43
|
1.46
|
0.43
|
0.61
|
0.62
|
0.57
|
0.48
|
0.83
|
0.25
|
0.18
|
0.89
|
0.36
|
0.63
|
-1.93
|
|
希薄化後一株あたり利益
|
0.42
|
1.44
|
0.42
|
0.6
|
0.61
|
0.56
|
0.47
|
0.81
|
0.24
|
0.18
|
0.88
|
0.36
|
0.63
|
-1.93
|
|
配当性向(%)
|
|
|
|
|
|
|
|
|
|
|
-
|
-
|
-
|
-
|
|
一株あたり配当金
|
0.28
|
0.35
|
0.28
|
0.28
|
0.28
|
0.28
|
0.28
|
0.28
|
0.28
|
0.28
|
-
|
-
|
-
|
-
|
|
EBITDA
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
EBITDAマージン(%)
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|